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ABSTRACT  We have introduced the gene for human growth hormone (hGH) into PC12 cells, 
a  rat  pheochromocytoma-derived  cell  line  with  neuronal  characteristics,  and  have  isolated 
stable cell lines that express this protein, hGH is stored within the cells in membrane-bounded 
vesicles  that are indistinguishable  from the endogenous catecholaminergic  synaptic vesicles. 
When the transfected  cells are stimulated  by carbachol or direct depolarization, they release 
norepinephrine and hGH with parallel kinetics. Treatment of the transfected  cells with nerve 
growth factor results in a twofold increase  in the amounts of hGH stored in and secreted from 
the cells.  Not all proteins are packaged  into the synaptic vesicles,  since the rate of release of 
laminin, a soluble secreted protein endogenous to PC12 cells,  is not stimulated by carbachol. 
This neuronal cell line therefore possesses at least two distinct pathways for secretion and can 
selectively package  a foreign endocrine hormone into the regulated pathway. 
All nucleated cells secrete cellular products into the extracel- 
lular medium. This function is highly developed in some cells, 
notably granulocytes, endocrine, exocrine, and neuronal cells, 
in which the secretory process is regulated by physiological 
stimuli.  In  all  these  cells,  proteins  or small  molecules are 
stored within specialized secretory vesicles and are released 
from the  cell  by fusion  of the  vesicle membrane with  the 
plasma  membrane.  However,  some  details  of this  process 
differ between these cell types. Neurons, for example, package 
different compounds into  vesicles than  do endocrine  cells, 
transport these vesicles great distances from the cell body, and 
release them at specialized synaptic sites.  We do not know 
whether all these cells use  similar molecular machinery to 
carry out these secretory processes, or whether each has de- 
veloped distinct pathways. If similar machinery is needed by 
various  cells,  one  would  predict  that  secretory  vesicles of 
different cell types would share common components. How- 
ever,  analysis of the  major proteins of adrenal  chromaffin 
granules, zymogen granules from the exocrine pancreas, and 
serotonin  granules  from  platelets  revealed  no  components 
that were common to all vesicles (31).  In contrast, immuno- 
logical analysis has identified two antigenic components that 
are shared between the secretory vesicles of endocrine and 
neuronal cells (2, 24). 
The classic way to show that different cell types carry out a 
cellular process with similar molecular machinery is to recon- 
stitute the process in vitro and interchange components from 
different origins. In this way, for example, the machinery for 
translocating  newly  synthesized  secretory  proteins  across 
rough endoplasmic reticulum membranes was shown to be 
universal (39).  More recently, it has been possible to show 
similarities in  molecular mechanisms by introducing  heter- 
ologous  gene  products  by  DNA  transfection.  Thus,  when 
African green monkey kidney cells (11), L cells (20), or COS 
cells (18) are transfected with DNA encoding proinsulin, the 
cells secrete proinsulin into the medium constitutively, that 
is, without storage and in the absence of an external signal 
(1 l, 20). When similar plasmids are transfected into a mouse 
pituitary  cell  line,  AtT-20,  that  stores  adrenocorticotropic 
hormone  (ACTH)  ~ in  secretory  vesicles,  the  proinsulin  is 
stored  in  the  secretory vesicles and proteolytically cleaved. 
When the cells are stimulated to release stored ACTH, they 
also release stored insulin (27). A similar capacity for storage 
and regulated secretion was observed when GH4 ceils were 
transfected with DNA encoding preproparathyroid hormone 
(13).  These experiments showed that African green monkey 
Abbreviations used in this paper. ACTH, adrenocorticotropic  hor- 
mone; DME, Dulbecco's modified Eagle's medium; G418, geneticin; 
hGH, human growth hormone; N-det, buffer containing 1% Nonidet 
P-40, 0.4% deoxycholate, 66 mM EDTA, and l0 mM Tris-HCl, pH 
7.4; NE, norepinephrine; NGF, nerve growth factor; SAC, Staphylo- 
coccus aureus cells. 
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process  proinsulin,  whereas  in  pituitary-derived  secretory 
cells,  the  molecular  machinery  for  packaging  endogenous 
hormones into secretory vesicles can recognize peptides from 
different  cell  types and  different  species.  The  capacity for 
proteolytic processing is not limited to specialized secretory 
cells,  since  preprosomatostatin and  preproparathyroid hor- 
mone are processed to mature hormones in COS cells  (40) 
and 3T3 cells (13), respectively. 
In this paper, we extend the DNA transfection approach to 
look for similarities between endocrine and  neuronal cells. 
We have developed procedures for transfecting DNA encod- 
ing an endocrine product, human growth hormone (hGH), 
into a rat pheochromocytoma cell line (PC12) that has neu- 
ronal properties. These include the ability to synthesize and 
package norepinephrine (NE) and acetylcholine into synaptic 
vesicles,  sensitivity to NGF (10),  and the ability to send out 
long neuritic processes (21)  and to form synapses with cul- 
tured myotubes (35).  We have therefore used PC12 cells to 
examine the capacity of cells with a  neuronal phenotype to 
package and secrete a foreign endocrine hormone. Gumbiner 
and Kelly (12)  first reported the coexistence of constitutive 
and regulated pathways for protein secretion in AtT-20 cells. 
It has recently been possible to use DNA transfection proce- 
dures to demonstrate that there is also a segregation of  secreted 
proteins into these two pathways (reference 3; and Moore, H. 
P.,  and R. B. Kelly, personal communication). By studying 
the kinetics of secretion release of dopamine/3-hydroxylase, 
McHugh et al. (25) have provided evidence for the existence 
of a regulated and a constitutive pathway in PC 12 cells. They 
suggest that dopamine/3-hydroxylase enters both pathways so 
that a fraction of dopamine ~-hydroxylase is secreted consti- 
tutively, while the  remainder is stored within  the cells and 
released upon stimulation. In addition to demonstrating that 
PC12 cells can package and secrete a foreign endocrine hor- 
mone, we present additional evidence to support the existence 
of consitutive and regulated secretory pathways in PC12 cells. 
We  also  show  that  PC12  cells  can  sort  secretory proteins 
selectively into one of these two pathways with a  high effi- 
ciency. 
MATERIALS  AND  METHODS 
Materials and Solutions 
Geneticin (G418)  was obtained from Gibco Laboratories (Grand Island, 
NY). The G418 was titrated for the killing  of untransfected PC 12 cells, and 0.5 
mg/ml of active drug was found to be optimal. The drug was mixed with 
culture media in 100× stock solutions, adjusted to neutral pH, sterile filtered, 
and stored at -20"C for no longer than 2 too. 
The TE buffer  used for DNA transfections contained 10 mM Tris,  1 mM 
EDTA,  pH 8.0. HeBS contained 137 mM NaCI, 5 mM KCI, 5.5 mM glucose, 
0.8  mM Na2HPO~, and 21  mM HEPES,  pH 7.05.  The detergent extraction 
buffer used for determining  the hGH content of cells  contained 150 mM NaCI, 
1.5 mM MgCI2, 0.5% Triton X-100, and 10 mM Tris, pH 7.5. Just before use, 
protease inhibitors were added in the form of a  100× stock solution in 100% 
ethanol of phenylmethylsulfonyl  fluoride and iodoacetamide to final concen- 
trations of 300 t@/ml each.  N-clef buffer for immunoprecipitations  contained 
I% Nonidet P40, 0.4%  deoxyeholate,  66 mM EDTA,  and  10 mM Tris-HCl, 
pH 7.4. Phosphate-buffered  saline (PBS) contained 150 mM NaC1 and 20 mM 
NaH2PO4, pH 7.4. 
DNA Vectors 
The pRSV-CAT  (chloramphenicol acetyltransferase)  has been described  by 
Gorman et al. (7); pSV2neo:hGH was a generous gift from Dr. Michael Walker 
(University  of California, San Francisco) and consists ofa 2.6-kb genomic hGH 
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sequence (5), including the 5' flanking sequences,  inserted into the EcoRI site 
of pSV2neo  (36) in both orientations. Thus,  both the selected marker (neo) 
and the nonselected  marker (hGH) were present on the same plasmid. 
Cell Culture 
PCI2 cells, originally  described by Greene and Tischler (9), were obtained 
from University  of California (San Francisco) cell culture stocks and grown in 
Dulbecco's modified Eagle's medium (DME)  H-21  +  10% fetal calf serum + 
5% horse serum at 37"C in 9.5% CO2 (pH 7.4). Cells were grown on untreated 
tissue culture plastic (Falcon Labware, Oxnard, CA) and passaged by treatment 
with trypsin and EDTA.  Nerve growth factor (NGF) was purified from mouse 
salivary  glands by the method of Mobley et al. (26) and added and assayed for 
biological activity  by monitoring the outgrowth of cell processes by PCI2 cells. 
When used in these experiments, NGF (2-l0 ng/ml) was added at 10-50 times 
the amount needed for maximal effects on morphology. 
Transfection of PC 12 Cells 
PCI2 cells were  transfected  by a  modification of the calcium phosphate 
procedure described by Moore et al. (27). On the day before transfection,  3 × 
106  PC12  cells were  plated onto  poly-D-lysine-coated  10-cm plastic tissue 
culture dishes and allowed to adhere overnight.  The plasmid DNA was added 
to HeBS-rinsed  cells in the form  of a  calcium phosphate precipitate (8) and 
allowed to settle onto the cells for 20 min at room temperature. DME H-21 + 
5% fetal calf serum was then added, and the cells were placed in an incubator 
for 4-7 h to permit the uptake of the DNA-CaPO4 precipitate.  The cells were 
then subjected to osmotic shock by incubation in 25 % glycerol in DME H-21 
for  1 min and then rapidly washed with DME H-21 (without serum).  The 
medium was then switched  to standard culture medium, and the cells were 
replaced  in the incubator. The remainder of the transfection was done essen- 
tially as described by Moore et al. (27). 
The  optimal amount  of DNA  for  transfection  was  determined using a 
transient expression  assay with an RSV-CAT plasmid (7). Expression of CAT 
was approximately  linear up to 25 ~g of DNA/3 x  106 cells; above this amount, 
the level of expression  plateaus.  For stable transfections,  20 ~g of DNA/3 × 
106 cells was routinely used. This amount generally resulted in the selection of 
10-30 clones/10-cm dish. For selection of eells  transfected with pSV2neo:hGH, 
medium containing 0.5 mg/ml G418 was added to the cells on the second day 
after  transfection and fed  with the same medium as needed.  After  ~3  wk, 
individual clones were transferred  to wells containing medium + 0.25  mg/ml 
G418 and grown to sufficient density to screen for hGH secretion.  No clones 
grew in dishes that were treated identically  except for the omission of DNA in 
the CaPO4 precipitate.  When the selected clones reached about half  confluency, 
the culture media were assayed for hGH content. Positive clones were main- 
tained in 0.25 mg/ml G418 thereafter. 
Cell Stimulations 
The standard stimulation protocol was performed on parallel 10-cm dishes 
of PC 12 cells at about one-half confluence.  To quantitate stimulated secretion, 
cells were incubated for several hours in the presence of 1 uCi [3H]NE (Amer- 
sham Corp.,  Arlington Heights,  IL) and then rinsed three times with fresh 
medium. The cells were incubated in 4 ml of medium +  5 mM carbacbol, and 
the medium was changed at 2-min intervals. At the end of the experiment, the 
cells were rinsed three times with PBS to remove serum and extracted with 4 
ml of  detergent extraction  buffer. Cells were removed from the dish by scraping, 
freeze-thawed three times, and centrifuged to remove insoluble  cell debris. This 
extract was then diluted and assayed for hGH. 
Subcellular Fractionation 
Ceils  were fractionated on a sucrose equilibrium density gradient essentially 
as described  by Schubert  and  Klier (34).  PCI2  cells were  grown  to  near- 
confluency in  15-cm dishes.  Several  hours before  harvesting,  fresh  medium 
containing 5 ~Ci [3H]NE was added.  Cells were removed by rinsing the dish 
twice with PBS and then adding PBS containing 5 mM Mg-EGTA at 0*C. Cells 
were removed by trituration and homogenized in a tight-fitting Dounce ho- 
mogenizer  (Kontes Glass  Co., Vineland, N  J) with 25 strokes at 0*C. This entire 
homogenate  was layered onto a linear sucrose gradient (0.6-2.0 M) containing 
l  mM Mg-EGTA and 10 mM HEPES, pH 7.4. The gradients  were centrifuged 
at 100,000 g for 3 h at 4"C, and the fractions were collected from the bottom 
of the tube and assayed for protein, [3H]NE, hGH, and vesicle antigen.  Before 
aliquots of these fractions were assayed for hGH, they were added to an equal 
volume of  detergent extraction buffer, and freeze-thawed once. Sucrose concen- 
tration was determined by refractive index. Immunoprecipitations 
PCI2/I B6  VESICLES:  [3H]NE-labeled cells were removed from the cul- 
ture dish with PBS +  10 mM EGTA, and homogenized by 10 passes at 0*C in 
a  custom-made  homogenizer  (EMBL, Heidelberg, FRG),  with  a  0.012-ram 
clearance.  100-~d aliquots  of this homogenate  were incubated  with  2  t~l  of 
culture medium or culture medium containing monoclonal antibodies directed 
against synaptic vesicles at 0*C for 2 h. The antibodies used were anti-SV2 (2) 
and anti-P65  (referred to as serum 48 in reference 24). Fixed Staphylococcus 
aureus cells (SAC) (Pansorbin, Calbiochem-Behring Corp., La Jolla, CA) were 
pretreated  with unlabeled, untransfected  PC I2 cell membranes to reduce non- 
specific binding and then incubated with the antibody-treated  homogenate for 
30 rain at 0*C. The suspension was then centrifuged 2 min in a Fisher microfuge 
( 12,000 g) (Fisher Scientific Co., Pittsburgh, PA), and the pellet was resuspended 
in  I ml PBS containing  1% bovine serum albumin (BSA) and 5 mM EGTA. 
This was layered on top of 0.5 ml of 30% sucrose in PBS/BSA/EGTA  buffer 
and centrifuged for 5 min in a microfuge. The resulting pellet was resuspended 
in  detergent  extraction  buffer  including  phenylmethylsulfonyl  fluoride  and 
iodoacetamide, and was assayed for [SH]NE and hGH. 
aSS-LABELED PROTEINS:  Immunoprecipitations from culture  media 
were done by incubating  media samples, pretreated with SAC and prespun for 
15 min in a microfuge, with the appropriate  dilution of antiserum  for 12 h at 
4"C. Antibodies used were goat anti-hGH (Antibodies Inc., Davis, CA), rabbit 
anti-laminin  serum kindly provided by Janet Winter (University of California, 
San Francisco), or the corresponding  nonimmune goat or rabbit serum.  Pre- 
washed SAC was added  to these samples and incubated  at 25"C for  15  min. 
The SAC was then pelleted by spinning  1 min in a microfuge, resuspended in 
N-det plus 0.3% SDS, and pelleted through 30%  sucrose in N-det plus SDS. 
The resulting pellet was washed once in N-det plus SDS, and once in water, 
changing tubes at each step. Antigen was solubilized by boiling the final pellet 
in SDS PAGE sample buffer and was applied directly to the gel for electropho- 
resis. 
SV2 Immunoreactivity 
The amount of SV2 antigen in membranes was determined  by quantitative 
dot  blotting  of fractions  essentially as described  by Carlson  and  Kelly (4). 
Fractions were solubilized in 2% SDS and applied to nitrocellulose filters in a 
96-well manifold (Bio-Rad Laboratories, Richmond, CA). The filters were then 
blocked with 50%  fetal calf serum and incubated  with monoclonal  anti-SV2 
and an ~2Si-goat anti-mouse IgG probe. 
hGH Assays 
hGH was determined  with a  murine monoclonal  radioimmune assay ob- 
tained from Hybritech Inc. (La Jolla, CA). This radioimmune assay showed no 
detectable cross-reactivity to rat growth hormone (unpublished  observations). 
Samples were prepared for hGH assay either by collecting the culture medium 
or by extracting  the cells with detergent.  Standard  curves were generated  in 
both the presence and absence of detergents. 
Protein Assays 
Protein concentrations  in sucrose gradients were determined  by the method 
of Bradford (1). Cell extracts, which contained detergent, were assayed with the 
Amido Schwarz assay (33) using BSA as a standard. 
SDS PAGE and Autoradiography 
Samples were boiled in SDS and B-mercaptoethanol-containing  buffer and 
separated  on polyacrylamide  gels according to the method of Laemmli  (16), 
using 12% acrylamide gels for hGH and 3SS-labeled media, and 4-12% gradient 
gels for laminin,  using Sigma molecular  weight markers  (MW-SDS-70L and 
MW-SDS-200, Sigma Chemical Co., St. Louis, MO). For autoradiography, gels 
were soaked in l M salicylate for t/2 h, dried, and used to expose Kodak X-ray 
film at -70"C. 
RESULTS 
Expression and Storage of hGH in Transfected 
PC 12 Cells 
Growth  hormone  is  normally expressed and  secreted  in 
somatotroph cells of the anterior pituitary (14).  These cells 
store  growth  hormone  in  dense  granules  contained  in  the 
cytoplasm.  To  examine  how  a  cell  line  with  a  neuronal 
phenotype would secrete this endocrine hormone, we trans- 
fected (rat) PC 12 cells with a vector containing both the gene 
for hGH and the selectable marker for neomycin resistance. 
Selection with G418-containing medium resulted in the iso- 
lation of 31 clones. These clones were then screened for their 
ability to express and  secrete hGH by assaying the  culture 
medium with a monoclonal radioimmune assay that specifi- 
cally detected human but not rat growth hormone (unpub- 
lished observations). Thirteen of the clones (42%) expressed 
detectable levels of hGH. We chose one of  these clones (PC 12/ 
IB6) for further characterization. 
To  determine  whether  the  transfected  PC12  cells  were 
secreting authentic hGH, we metabolically labeled PC 12/1 B6 
cells with [35S]methionine  and [35S]cysteine. The culture me- 
dium was collected and immunoprecipitated with goat anti- 
hGH antibody. As shown in Fig.  1,  one major protein was 
precipitated that co-migrated with the purified hGH standard 
(22,000 mol wt). A second, minor band was present with an 
Mr  of 2,000  less  than  that  of the  major  form;  this  band 
probably represents the 20,000 form of hGH that is found in 
human pituitary at a  level of -1/10  the 22,000  form (19). 
Neither of these bands was present in precipitations carried 
out with nonimmune serum (lane  1) or in immunoprecipi- 
tations of untransfected PC 12 cells (data not shown). A third, 
faint band represents a nonspecifically precipitated protein of 
Mr 21,000.  On other gels, this band is clearly distinct from 
the two specifically precipitated bands. Densitometry of au- 
toradiograms from two independent collections and immu- 
noprecipitations gave a ratio of 10.6 _+ 0.8 for the 22,000 and 
20,000 forms secreted by the transfected PC 12 cells. Since we 
have introduced only one gene for hGH into PC12 cells, the 
present data consitute direct evidence that both 22,000 and 
20,000 forms of hGH can be produced from the same gene. 
It is clear that PC12  cells  possess the proper machinery to 
express and  secrete hGH in  a  form indistinguishable  from 
that produced by the human pituitary. 
In  previous  experiments  in  which  growth  hormone  has 
been introduced into fibroblast (6)  or monkey kidney cells 
(28), no storage of the gene product was observed. In contrast, 
PC12  cells,  which  store neurotransmitter and  release it on 
stimulation, have the capacity to store hGH (Table I). If we 
assume that all of the hGH that is synthesized is eventually 
secreted, then at a steady-state the rate of synthesis should be 
equivalent to the rate of basal release of hGH. By dividing 
the total amount ofhGH present in cell extracts by the steady- 
state rate of secretion, we obtained a storage index, which is 
a measure of the amount ofhGH that is stored intracellularly. 
Thus, in the experiment shown in Table I, PC I2/1B6 cells 
stored substantial amounts of hGH equivalent to the amount 
synthesized in 137 min. This index is similar to that obtained 
for all forms of ACTH secretion by the pituitary cell line AtT- 
20 (Burgess,  T., and H.-P. Moore, personal communication) 
and is higher than that observed for the proinsulin expressed 
by L cells, which do not store secretory products intracellutarly 
(storage index =  66  min, calculated from data in reference 
27).  Since intracellular storage is a property of the regulated 
secretory pathway (37),  this result suggested that PC12/IB6 
cells were packaging hGH into some furm of regulated secre~ 
tory vesicles. 
SCHWEITZER AND  KELLY  Human Growth Hormone in PC12 Cells  669 FIGURE  1  Immunoprecipitation of  hGH  secreted  by  PC12/1B6 
cells. Two 10-cm dishes of PC12/1B6 cells, grown in the absence 
of NGF, were labeled by incubation in medium containing 1/50 the 
normal amount of cysteine,  10% dialyzed fetal calf serum, and 0.25 
mCi [35S]cysteine.  After 9 h, the medium was removed and precip- 
itated as described  in Materials and Methods. After immunoprecip- 
itation, the samples were dissolved in SDS PAGE sample buffer by 
boiling, and separated on a 12% gel. Purified  hGH and molecular 
weight markers were run  in  adjacent  lanes; arrows  indicate the 
mobility of these standards. After staining the gel with Coomassie 
Brilliant Blue, the gel was soaked for 30 min in 1 M salicylate, dried, 
and exposed for autoradiography. Lane 1, precipitation with normal 
goat serum; lane 2, parallel precipitation with goat anti-hGH. 
Release of hGH and NE 
If the stored hGH is contained in  normal PC I2 synaptic 
vesicles,  it should be possible to increase the rate of secretion 
by treating the cells with physiological secretagogues. Since 
PC I 2  cells  possess acetylcholine receptors, we  used  5  mM 
carbachol to depolarize the cells. Such treatment produced a 
15-fold increase in the rate of  release ofhGH (Table I). Similar 
results (data not shown) were obtained by depolarizing the 
cells with 51  mM KC1. 
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As judged  by  morphological criteria  (cell  flattening  and 
outgrowth  of multiple  neuritic  processes),  PC12/1B6  cells 
were  indistingusihable  from  untransfected  control  cells  in 
their  response  to  NGF.  Table  I  indicates  that  NGF  also 
affected the storage and secretion of hGH. Whereas the rate 
of basal secretion (and presumably synthesis) of hGH was not 
significantly altered by NGF treatment, the storage capacity 
of the  cells increased  more than  twofold  (storage index  = 
300).  NGF treatment also  increased the  stimulated  release 
about twofold to more than  25  times the  basal rate.  Since 
both the storage and stimulated release of hGH increased in 
parallel, the additional storage appears to reflect an increased 
capacity of the NGF-treated cells to package and store hGH 
in  synaptic  vesicles.  The  increase  in  the  efficiency of this 
storage with NGF treatment suggests  that  differentiation  is 
accompanied by an increased efficiency of  protein sorting into 
synaptic vesicles.  We conclude that at least part of the hGH 
stored in the cells is in some type of secretory vesicle whose 
fusion with the plasma membrane can be stimulated by cell 
depolarization. The properties of this secretion can be con- 
trasted with those observed in the endocrine cell  line, AtT- 
20,  in which cAMP causes a stimulation of secretion that is 
two to five times the basal rate; depolarization of these cells 
with KC1 is even less effective (12, 24). 
In  contrast  to  the  slow  rate  of stimulated  secretion  of 
hormones  by  endocrine  cells  (24),  PC12  cells  release  NE 
within  minutes  of stimulation  (10).  If the  pool of vesicles 
containing  hormone differed from the  pool that  contained 
neurotransmitter, hGH and NE might be secreted with differ- 
ent  kinetics.  We  found  that  when  NGF-treated PC12/1B6 
cells  were  exposed to  5  mM  carbachol,  there  was a  rapid 
stimulation of NE release that peaked within 2 min (Fig. 2). 
In spite of the continued presence of secretagogue, the release 
rate returned to baseline over the next 10 min. Since such a 
decrease has been observed in the release of transmitter from 
PC12  cells  stimulated with  51  mM KC1 (10),  this decay of 
release  is  most  likely due  to  inactivation  of the  secretory 
process rather than repolarization of the cells due to desensi- 
tization of the acetylcholine receptor. Both the rise and fall of 
hGH release paralleled that of [3H]NE from these same cells 
(Fig.  2),  suggesting that the secretion of both compounds is 
under similar regulation. In this experiment, the total amount 
of [3H]NE released in  10 min was 51.1  +  0.2%  of the total, 
whereas  42  __.  2%  of the  hGH  was  released  (Fig.  3).  The 
slightly lower fraction of hGH released may reflect its presence 
in  other,  nonreleasable  compartments in  the  cell,  such  as 
rough endoplasmic reticulum and Golgi. Examination of the 
amount of hormone recovered in cell extracts demonstrated 
that  hGH  is  depleted  from the  cells concurrently  with  its 
appearance in the bathing medium. Stimulation for 10 min 
resulted in a 42% decrease in hGH content of the cells (Fig. 
3); this decrease can be completely accounted for by the hGH 
recovered in  the  bathing  media.  We conclude  that  protein 
degradation plays no significant role in the turnover of hGH, 
at least on this time scale. Similar experiments performed on 
non-NGF-treated cells gave qualitatively similar results.  How- 
ever,  as  indicated  by  Table  I,  the  amount  of stimulation 
compared with the basal release was not as great. 
Packaging of hGH into Synaptic Vesicles 
The most likely explanation for the increased rate of secre- 
tion produced by secretagogue is that hGH is packaged into TABLE  I.  Storage  and Secretion of hGH by PC-12 Cells 
Stimulated/ 
Total hGH content  Basal release  Storage index  Stimulated release  basal 
nglmg protein  nglmg min (% total/rain)  min  ng/mg min (% total/rain) 
No NGF  5.6 ___ 1.6  0.041 4- 0.014  137  0.63 +  0.02  15 
(0.61  4- 0.18)  (7.7 +  0.4) 
N GF-treated  17.3 4- 2.0  0.057 4- 0.005  304  1.48 +  0.13  26 
(0.31  +  0.01)  (8.99 _+ 0.28) 
Basal and stimulated secretion of hGH. Cells were grown in 10-cm dishes for 4 d either in the presence or absence of 10 ng/ml NGF, and fed daily. To measure 
rates of secretion, media (_+ 5 mM carbachol) were changed at 2-min intervals. The collected media were centrifuged at 200 g for 5 min to remove cell debris, 
and then assayed for hGH. At the end of 10 rain of collection, the hGH remaining in the cells was determined by rinsing the cells three times with  PBS to 
remove protein from the media, and then extracting with detergent extraction buffer. This extract was also centrifuged to remove nuclei and cell debris, and 
then assayed for hGH and protein. The storage index represents the total hGH content divided by the rate of basal release. 
30  I  +5 mM Carbachol  I 
T  r  0  _,  ~  ~  ~  ~ 
Time (Minutes) 
FIGURE  2  Stimulated  secretion  of  [3H]NE  and  hGH.  PC12/1B6 
cells were plated  into four  10-cm  dishes and grown  for 4  d  in the 
presence of NGF. The cells were loaded for 2  h with  1/~Ci  [3H]NE 
and  then  washed  three  times  with  normal  medium.  The  media 
were then changed in 2-min intervals; beginning at t =  0, one pair 
of dishes  received  medium  without  (O,  @)  or with  (A,  &)  5  mM 
carbachol. The  media were collected, centrifuged  to remove any 
cell debris, and assayed for [3H]NE (O, A) and hGH  (@, A). At the 
end of the stimulation period, the cells were extracted with deter- 
gent, and the amounts of [3H]NE and hGH  remaining in the cells 
were determined. Secretion is expressed as percentages of the total 
[3H]NE and hGH  recovered in the media and extracts. 
o 
20 
~o 
the endogenous synaptic vesicles in PCI2 cells. To test this 
hypothesis, we have used two separate criteria to determine 
the intracellular localization of the hGH: immunoprecipita- 
tion with vesicle-specific  antibodies and co-purification with 
[3H]NE on subcellular fractionation. 
Synaptic vesicles from PCI2/1B6 cells were immunopre- 
cipitated  from  homogenates  using  monoclonal  antibodies 
known to bind proteins on the cytoplasmic surface of secre- 
tory vesicles.  The first antibody, BM48, binds to a  protein 
(M, 65,000) in the vesicle memebrane, and has been used to 
immunoprecipitate  catecholaminergic  vesicles  from  PC12 
cells (24). The second antibody, anti-SV2, binds to the cyto- 
plasmic portion of a  vesicle-specific  glycoprotein (2).  Both 
vesicle  antigens are  found in  many species  and  in  a  wide 
variety of endocrine and neuronal tissue.  Table II shows that 
incubation of the  PC12  homogenate with  these antibodies 
followed by precipitation with SAC resulted in the specific 
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FIGURE  3  Depletion of hGH  from cells  by stimulation. The total 
amount of hGH released in the experiment described in Fig. 2 was 
obtained by summation of hGH recovered in the media during 10 
min  of incubation +  5  mM carbachol.  Both the amounts of hGH 
secreted and recovered in the cell extracts are normalized to the 
amount of  cellular  protein  recovered  in  the  cell  extracts.  These 
amounts were 2.1 4- 0.2 and 2.2 ___ 0.2 mg/dish for the unstimulated 
and stimulated cells, respectively. 
precipitation of synaptic vesicles, as indicated by the precipi- 
tation  of [3H]NE.  Moreover, both  these  antibodies  could 
specifically  immunoprecipitate 40-45% of the total hGH in 
the  PC12  cell  membranes;  this  figure  coincides  with  the 
amount released by stimulation in the preceding experiment. 
By immunological criteria, the hGH in PC 12 cells is contained 
in synaptic vesicles. 
Synaptic vesicles can also be isolated from PC 12 cells by 
equilibrium density centrifugation. These vesicles have been 
reported to band at  1.2 M  (34)  or  1.4 M  (29)  sucrose.  As 
shown in Fig. 4a, when [3H]NE-loaded PC12/IB6 cells were 
fractionated on such a gradient, there is a  peak of [3H]NE 
found at  1.4 M  sucrose (open triangles).  In addition to this 
peak, there is some [aH]NE found at the top and bottom of 
the gradient; the former presumably represents [3H]NE  re- 
leased from vesicles  lysed during homogenization, and the 
latter, vesicles trapped in undisrupted cell debris.  To confirm 
the identity of the secretory vesicle peak, the amount of the 
secretory  vesicle antigen, SV2, was assayed across the gradient. 
The binding of anti-SV2 (open circles) also peaked at 1.4 M 
sucrose, even though the total amount of  protein in this region 
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the gradient (closed triangles) revealed that it co-localized with 
the [3H]NE and SV2 antigen, supporting the hypothesis that 
the  hGH  is  contained  in  catecholaminergic  vesicles.  It  is 
important to  note that the hGH  is enriched in the vesicle 
peak, rather  than simply following the protein distribution. 
The specific activity (ng hGH/mg protein) is highest in frac- 
tion 9 (1.4 M sucrose), coincident with the peak of vesicular 
[3H]NE. We therefore  conclude that the hGH is selectively 
TABLE II.  Immunoprecipitation of PC12/1B6 Vesicles 
Antibody  [~H]NE  hGH 
cpm (% total)  ng (% total) 
Culture medium  295 +  9  (28)  0.16 +  0.01  (33) 
Anti-SV2  733  +  44 (70)  0.37 _+ 0.05 (78) 
Anti-P65  822  -  82 (78)  0.34 +  0.30 (73) 
[~H]NE-labeled  PC12/1 B6 cells  were homogenized  in  PBS +  10 mM EGTA, 
and  the  membranes  were  incubated  with  culture  medium  or  monoclonal 
antibody-containing  medium.  The  vesicles  were  precipitated  with  SAC as 
described  in Materials and Methods. The total  [~H]NE  and hGH  contained 
in  the  PC12/1B6  membranes  was  determined  by  centrifuging  aliquots  at 
18,000 g for 15 rain  and assaying the pellets  for [~H]NE  and hGH. 
localized within membrane vesicles that co-purify with PC I2 
catecholaminergic vesicles. 
If these vesicles form the basis for the stimulated secretion 
illustrated in Fig. 2, it should be possible to deplete this vesicle 
peak of hGH. Fig. 4 b shows a gradient profile from cells that 
were treated in parallel with those in Fig. 4 a, except that these 
cells were stimulated for l0 min with 5 mM carbachol before 
homogenization. In this experiment, stimulation resulted in 
a 25%  decrease  in the total cellular hGH. A comparison of 
parts a and b of Fig. 4 reveals that there is a decrease  in the 
amounts of [aH]NE  (open triangles)  and hGH (closed trian- 
gles)  recovered  in  the  vesicle  peak,  although there  is  no 
decrease  in either the total protein or the amount of vesicle 
antigen. Summation of the hGH recovered in the correspond- 
ing vesicle fractions (1. l-1.5 M sucrose) in gradients 4 a and 
4b  indicate that the  hGH  recovered  in  this  region  of the 
gradient is decreased  by 24% (7.0 ng vs 5.3 ng). There is also 
a decrease  in the [3H]NE and hGH recovered at the top and 
bottom of the gradient, as would be expected if these represent 
lysed and trapped vesicles.  The above data demonstrate that 
PC12 cells can package  hGH into membranous vesicles that 
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FIGURE  4  Subcellular  fractiona- 
tion  of  PC12/186  cells  with  or 
without  stimulation. Two parallel 
15-cm dishes of cells were loaded 
with 5 #Ci  [3H]NE each for 12 h. 
The cells were then washed twice 
with fresh  medium and then  in- 
cubated  for  10  min  in  medium 
without (a) or with (b) 5 mM car- 
bachol, washed twice with  PBS, 
and removed from the dish with 
PBS  containing 10  mM  EGTA at 
0°C. The cells were then homog- 
enized,  layered  onto  sucrose 
gradients, and centrifuged to equi- 
librium.  Recovery  of  protein 
from  the  two  gradients  was 5.10 
and  5.12  mg.  Concentration  of 
sucrose (-0--)  was calculated 
from  refractive  index.  Protein 
(~),  [3H]NE (A), hGH (A), and 
SV2  immunoreactivity  (O)  were 
assayed as described in Materials 
and Methods. 
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the endogenous catecholaminergic vesicles,  and that the cells 
can  release  hGH  from this  vesicle  pool  upon  appropriate 
stimulation. 
Sorting of Secreted Proteins into Two Pathways in 
PC 12 Cells 
If PCI2  cells package all  newly synthesized protein  into 
secretory vesicles,  it would not be surprising to find hGH co- 
localizing with NE. On the other hand, some cells possess two 
separate pathways for secretion of proteins (12). To determine 
whether separate secretory pathways exist in PC I2 cells,  we 
pulse-labeled PC12/IB6  cells  with  [35S]methionine  and  fol- 
lowed  the  secretion  of proteins  during  four  10-min  chase 
periods. As shown in  Fig.  5,  there is a  gradual chase-out of 
labeled proteins (a,  lanes  1,  2,  3,  and  4)  in  the  absence of 
stimulation. However, the  addition  of carbachol during the 
third and fourth chase periods (b, lanes 3 and 4) resulted in a 
dramatic stimulation of the secretion of some proteins (com- 
pare a, lane 3, with b, lane 3), for example those of Mr 39,000 
and 78,000 (closed arrows). Although we have not identified 
these stimulated proteins, they are likely to include the chrom- 
ogranins, which are soluble protein components ofchromaffin 
granules (29,  41).  In contrast, other proteins such as those of 
Mr  32,000  and  81,000  (open  arrows)  were  secreted  con- 
stitutively, i.e., their secretion was not increased by carbachol. 
We interpret this result to mean that only a subset of all newly 
synthesized proteins are packaged into  the transmitter-con- 
taining synaptic vesicles whose fusion with the plasma mem- 
brane is stimulated by carbachol. 
A third pattern of secretion is exemplified by the band at 
Mr 73,000 (star), which is released in substantial amounts in 
the absence of stimulation, and increases about twofold in the 
presence of carbachol. This may represent the superposition 
of two  proteins,  one  secreted  constitutively  and  the  other 
released by stimulation. An alternative explanation is that this 
band  represents a  third  class of proteins that  is  not  sorted 
efficiently between the two pathways. McHugh et al. (25) have 
recently presented evidence that dopamine ~-hydroxylase (Mr 
73,000;  reference  32)  is  secreted constitutively and  that  its 
release is stimulated only about twofold by depolarization. 
To provide further evidence for the segregation and separate 
secretion of PC I2 cell proteins, we followed the secretion of 
laminin, a soluble protein which is known to be secreted by 
PC12 cells (17),  but which we did not expect to be packaged 
into secretory vesicles.  Laminin secretion was quantitated by 
immunoprecipitation with rabbit anti-laminin serum of the 
media samples from the same experiment described in Fig. 5. 
On reducing gels, laminin migrates as a heavy and light chain 
of Mr 400,000  and  200,000  (38).  Bands  co-migrating with 
laminin  standards  were specifically immunoprecipitated by 
antiserum  (Fig.  6b)  but  not  by  nonimmune  rabbit  serum 
(Fig.  6a).  Detectable amounts of laminin are secreted in  l0 
min in the absence of stimulation (Fig.  6 b, lanes 1 and 2); 
this secretion is not increased by carbachol (Fig.  6 b, lane 4). 
Laminin is therefore an example of a  constitutively secreted 
protein.  This lack of stimulation can be directly contrasted 
with  the  nonspecifically precipitated protein  of Mr  66,000; 
the secretion of this protein is markedly stimulated by car- 
bachol. We conclude from these experiments that PC12 cells 
segregate secreted proteins into at least two distinct pathways, 
distinguishable by their sensitivity to carbachol. The packag- 
FIGURE  5  35S-labeled proteins secreted by  PC12/1B6  cells.  Four 
10-cm  dishes  of  PC12/1B6  were labeled for  10  h  with  1 mCi  - 
[3SS]methionine, 0.5 mCi [3SS]cysteine,  and 2 ~Ci [3H]NE in medium 
containing 1/100 the normal amounts of methionine and cysteine. 
At the end of the labeling period, the media were removed and 
replaced with fresh  media at 10-min intervals.  One pair of dishes 
(a) was incubated with normal medium, collected at 10 min (1), 20 
min (2), 30 rain (3), and 40 rain (4) after labeling was discontinued. 
The second pair of dishes (b) was incubated in the same way except 
that the first  two incubations (I  and 2) were in  normal medium, 
and the second two (3 and 4) were in  medium containing 5 mM 
carbachol. Duplicate samples were pooled, and 5/~1 of each sample 
was separated on  a  12%  SDS  polyacrylamide gel  and  autoradi- 
ographed. The position of molecular  weight markers (in kilodaltons), 
visualized by Coomassie  Blue  stain,  are indicated along the left; 
closed arrows, indicate examples of stimulated proteins, open ar- 
rows indic'ate nonstimulated proteins. The star marks a band of Mr 
73,000. 
ing of hGH into secretory vesicles is therefore not simply a 
reflection  of the  bulk  flow  of secreted  proteins,  but  most 
involve an active sorting step at some point along the secretory 
pathway.  PC12  cells  can  selectively package hGH  but  not 
laminin into the endogenous, regulated secretory vesicles. 
DISCUSSION 
We have genetically inserted a foreign peptide hormone into 
a  neuronal cell line and have demonstrated that this altered 
cell line can secrete normal hGH in a physiologically regulated 
fashion. The ability of PC12 cells to carry out such secretion 
implies that they possess the cellular machinery to express the 
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cells. Pooled media from the experiment described in Fig. 6 were 
incubated with normal rabbit serum (a), or rabbit anti-laminin  serum 
(b),  precipitated with SAC and applied to a 4-12% gradient SDS 
polyacrylamide gel. The gel was stained  to visualize  laminin and 
molecular weight standards  and  processed  for autoradiography. 
Lanes 1 and 2 represent media collected during two successive 10- 
min  incubations in normal medium; lanes 3 and  4  represent  the 
same two periods, the first  in normal medium (3) and the second 
in 5 mM carbachol  (4). The location of laminin light chain (L) and 
heavy chain (H)  are  indicated along the  right;  molecular weight 
standards (in kilodaltons) are indicated along the left. 
gene, process the RNA, and package and release the peptide 
as if it were an endogenous neuropeptide transmitter. 
The construct used for these studies contained the genomic 
hGH coding sequence and 5' flanking region. The expression 
in PC 12 cells ofhGH encoded by this plasmid is not surprising 
since hGH has been expressed in a variety of cells, including 
flbroblasts and monkey kidney cells (28),  as well as AtT-20 
cells (27).  The expression ofhGH in PCI2 cells, albeit at low 
levels,  has  permitted  its  use  as  a  marker for the  study  of 
specificity in subsequent steps in packaging and secretion of 
peptides in a  neuronal cell line. Recent results indicate that 
approximately  50-fold  higher  levels  of expression  can  be 
obtained  by linking  the  hGH  gene  to  the  metallothionein 
promoter (unpublished  observations).  With  such  cell  lines, 
immunocytochemical localization of the hGH in PC12 cells 
should be feasible. 
The  transfected PC I2  cells secrete two peptides that  are 
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specifically  immunoprecipitated  by  anti-hGH  serum.  The 
mobilities of  these peptides correspond to those of  the 22,000- 
and 20,000-mol-wt forms of hGH produced by human pitui- 
tary cells (19). The smaller form, which is probably generated 
by alternative RNA splicing (5), has not been seen in monkey 
kidney cells containing the hGH gene (28). At present we do 
not know the molecular basis for the formation of the two 
forms observed in PC12 cells (but see reference 30). 
PC 12 cells are specialized for the storage and rapid release 
of transmitters. The experiments presented here demonstrate 
that these cells can store hGH in secretory vesicles until it is 
released by an appropriate secretagogue. In the  absence of 
NGF, transfected PC 12 cells  can store an amount of hGH 
equivalent to the amount they secrete in 2 h without stimu- 
lation. Treatment of the cells with NGF does not necessarily 
affect the expression ofhGH but increases the amount stored 
by 2.5-fold, indicating that differentiated PCI 2 cells are more 
efficient in storing this secretory peptide. The increased stor- 
age capacity could be due either to an increase in the number 
of storage vesicles with NGF, or to an increased amount of 
peptide packaged into each vesicle. The amount of hGH that 
is releasable by carbachol appears to  reflect the  amount of 
hGH in the synaptic vesicle pool, since NGF treatment pro- 
duces parallel increases in  stimulated release and storage of 
hGH. 
Whereas PC12  cells  store hGH with about the same effi- 
ciency as ACTH is stored by pituitary AtT-20 cells (Burgess, 
T., and H.-P. Moore, personal communication), they release 
large amounts of the  stored peptide hormones much more 
rapidly; carbachol causes a 26-fold stimulation of hGH secre- 
tion  by NGF-treated PC12  cells,  resulting in  the  release of 
40% of the total stored hGH in  l0 rain. In contrast, stimula- 
tion  for AtT-20  cells  causes a  3-5-fold increase  in  ACTH 
release by AtT-20 cells (23), resulting in a 20% depletion in 1 
h (Moore, H.-P., personal communication). The high level of 
regulation and the rapid rate of secretion seen in PC 12 cells 
may be a reflection of their neuronal character. 
The observation that the rate of hGH secretion is indistin- 
guishable from that of NE is significant for several reasons. 
First, it demonstrates that hGH is packaged into endogenous 
secretory vesicles in PC12 cells that not only share the same 
physical properties but also possess the same regulatory ele- 
ments as do the  synaptic vesicles.  PC12  cells  can therefore 
recognize a peptide hormone normally expressed in a different 
cell  type in  a  different species and  selectively package this 
hormone into a specific type of secretory vesicle. Despite any 
differences that exist between vesicles from various sources, 
the mechanism that permits selective packaging of peptides 
must  be  highly  conserved.  A  second  conclusion  from  the 
rapid kinetics of hGH release is that neurosecretory vesicles 
can be rapidly secreted on the first round of fusion with the 
plasma membrane. Neurons can package transmitters such as 
acetylcholine  and  NE  into  preformed  vesicles  from  cyto- 
plasmic pools.  Such  a  mechanism permits a  neuron  to  re- 
trieve, reload, and reuse vesicle membrane at great distances 
from the  cell body.  Peptides,  on  the  other hand,  must be 
packaged into vesicles at the Golgi apparatus and are presum- 
ably released during the  first fusion event with the  plasma 
membranes. In the case of vesicles that originally contain both 
neurotransmitter and peptides, such a system would create a 
difference between vesicles that have never fused with plasma 
membrane, and recycled vesicles, which would be depleted of 
peptides. Indeed, one explanation for the different frequency and calcium sensitivity seen between peptide and neurotrans- 
mitter release (22; see also reference  15) would be that newly 
synthesized vesicles fuse slowly with the plasma membrane, 
whereas recycled vesicles fuse rapidly.  The experiments  pre- 
sented  here  indicate  that,  at  least  in  PC I2  cells,  the  hGH- 
containing vesicles can carry out secretion as rapidly as would 
be expected for vesicles containing neurotransmitter alone. 
Third,  these  experiments  demonstrate  the  feasibility  of 
experimentally producing a cell that will secrete any particular 
peptide in a  rapid and highly regulated  manner.  If the gene 
for  that  specific  peptide  is  introduced  or  turned  on  in  a 
neuronal  cell,  the  existing  cellular  machinery  will  package 
and secrete the peptide in a manner characteristic of neuronal 
secretion. 
We  have  demonstrated  by  kinetic,  immunological,  and 
subcellular  fractionation  criteria  that  the  peptide  hGH  is 
packaged into vesicles indistinguishable from the endogenous 
NE-containing  vesicles.  Laminin,  an  endogenous  secretory 
protein  often  associated  with  the  extracellular  matrix,  does 
not appear to be released from these same vesicles. PC 12 cells 
thus possess at least two separate pathways for protein secre- 
tion and can segregate proteins selectively into at least one of 
the two pathways. The co-existence of two separate pathways, 
regulated  and  constitutive,  was  originally  described  in  the 
ACTH-secreting  endocrine  cell  line,  AtT-20  (12;  see  also 
reference 3). PC 12 cells provide a second example of the co- 
existence of these two pathways within a single cell.  In addi- 
tion to the ability to synthesize and package NE, PC 12 cells 
make  and  package  acetylcholine,  especially  after  treatment 
with  NGF  (10).  Since  these  two  transmitters  have been  re- 
ported to be packaged into separate vesicles (29, 34), there is 
a  possibility the PC12 cells possess more than one regulated 
pathway for secretion. It will therefore be important to deter- 
mine whether different soluble proteins are packaged into the 
two vesicle types. Such a difference would imply the existence 
of sorting  not  only between  the  regulated  and  constitutive 
pathways,  but  between  two  distinct  regulated  pathways  as 
well. 
Transfection of PC12 cells has been used here to study only 
one  property  of  neurons,  the  capacity  to  package  peptide 
hormones  correctly.  Now  that  a  neuronal  cell  line  can  be 
successfully  transfected,  however,  the  opportunity  exists  to 
create  new  cell  lines  that  express  additional  experimentally 
useful properties, to examine the regulation of neuronal gene 
expression  and the modulation  of this  expression  by NGF, 
and the elucidation  of other steps in the process of neurose- 
cretion. 
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